ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Oct 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2016-01-12

Reporting Person: GIVEN DOUGLAS B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-12	Common Stock	G	8000	$0.00	Disposed	82000	Direct
2016-10-14	Common Stock	S	12000	$6.72	Disposed	70000	Direct

Footnotes

F1: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.